|
| Exchange Disseminated Time | Kilitch Drugs India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 14, 2014, inter alia:
1. To take on record the Unaudited (Provisional) Financial Results for the Quarter ended June 30, 2014.
2. To adopt and approve the Notice and Directors' Report of the Company along with the Corporate Governance Report for financial year 2013-2014;
3. To finalize the dates of Book Closure for the purpose of forthcoming 22nd Annual General Meeting;
4. To finalize the date venue and time for convening 22nd Annual General Meeting of the Members of the Company;
5. To consider appointment of Scrutinizer to oversee the e-voting process of the Company at the 22nd Annual General Meeting.
Further, as per the Company's Code of Conduct for Prohibition of insider Trading, framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 1992, the Trading window for dealing in the securities of the Company will be closed for the purpose of declaration of financial results of the Company for the Quarter ended June 30, 2014 from August 01, 2014 to August 14, 2014. Accordingly, all the Designated Employees (including Directors) of the Company have been intimated not to enter into any transaction involving the securities of the Company during the aforesaid period of closure of trading window. |
|
|